BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron

Summary

Patients undergoing either an autologous or allogeneic hematopoietic stem cell transplant (HSCT) and receiving preparative chemotherapy experience a considerable amount of chemotherapy-induced nausea and vomiting (CINV). Current strategies at reducing CINV in this patient population are suboptimal due to lack of efficacy and supportive evidence, potential for increased adverse events, and drug-drug and drug-disease contraindications.

Timeline

Start

2020-05-14

Primary completion

2026-07

Completion

2026-07

Drugs

Indications